These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8835753)

  • 1. Modification of liposomes for liver targeting.
    Wu J; Zern MA
    J Hepatol; 1996 Jun; 24(6):757-63. PubMed ID: 8835753
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting of drugs to the liver.
    Meijer DK; Molema G
    Semin Liver Dis; 1995 Aug; 15(3):202-56. PubMed ID: 7491504
    [No Abstract]   [Full Text] [Related]  

  • 3. Targeting of liposomes to hepatocytes.
    Ghosh PC; Bachhawat BK
    Targeted Diagn Ther; 1991; 4():87-103. PubMed ID: 1724610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of therapeutics to the liver: liposomes and viral vectors.
    Di Campli C; Wu J; Zern MA
    Alcohol Clin Exp Res; 1999 May; 23(5):950-4. PubMed ID: 10371421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of cholesterol-based neoglycoconjugates and their use in the preparation of liposomes for active liver targeting.
    E Silva ATM; Maia ALC; de Oliveira Silva J; de Barros ALB; Soares DCF; de Magalhães MTQ; José Alves R; Ramaldes GA
    Carbohydr Res; 2018 Jul; 465():52-57. PubMed ID: 29944996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug targeting to the diseased liver.
    Poelstra K; Prakash J; Beljaars L
    J Control Release; 2012 Jul; 161(2):188-97. PubMed ID: 22370583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The liver-cell specific drug delivery system].
    Goto M
    Nihon Rinsho; 1994 Aug; 52(8):2214-24. PubMed ID: 7933613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery of oligonucleotides with lipid nanoparticles.
    Wang Y; Miao L; Satterlee A; Huang L
    Adv Drug Deliv Rev; 2015 Jun; 87():68-80. PubMed ID: 25733311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical demonstration of the action of liver drugs].
    Einsiedel-Schömer W
    Z Allgemeinmed; 1973 Oct; 49(30):1452-5. PubMed ID: 4588532
    [No Abstract]   [Full Text] [Related]  

  • 10. Fibrosis of the liver: the role of the ectoskeleton.
    Popper H; Martin GR
    Prog Liver Dis; 1982; 7():133-56. PubMed ID: 7051142
    [No Abstract]   [Full Text] [Related]  

  • 11. Limitations on the specificity of targeting asialoglycoprotein-drug conjugates to hepatocytes.
    van der Sluijs P; Meijer DK
    Targeted Diagn Ther; 1991; 4():235-64. PubMed ID: 1797158
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug therapy in liver disease].
    Jorup-Rönström C
    Lakartidningen; 1982 Apr; 79(14):1367-9. PubMed ID: 7087612
    [No Abstract]   [Full Text] [Related]  

  • 13. Hydrogen: a promising novel treatment for hepatic encephalopathy?
    Qu J; Lü X
    Free Radic Biol Med; 2013 Oct; 63():457-8. PubMed ID: 23743290
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibacterial activity of liposome-entrapped ampicillin in vitro and in vivo in relation to the lipid composition.
    Bakker-Woudenberg IA; Lokerse AF; Roerdink FH
    J Pharmacol Exp Ther; 1989 Oct; 251(1):321-7. PubMed ID: 2507773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of liposomes to liver cells.
    Scherphof GL; Spanjer HH; Derksen JT; Lázár G; Roerdink FH
    Horiz Biochem Biophys; 1989; 9():281-91. PubMed ID: 2656479
    [No Abstract]   [Full Text] [Related]  

  • 16. Targeting endoplasmic reticulum stress in liver disease.
    Wu FL; Liu WY; Van Poucke S; Braddock M; Jin WM; Xiao J; Li XK; Zheng MH
    Expert Rev Gastroenterol Hepatol; 2016 Sep; 10(9):1041-52. PubMed ID: 27093595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The substantiation of UDCA usage in functional disorders of biliary tract].
    Il'chenko AA
    Eksp Klin Gastroenterol; 2011; (9):108-12. PubMed ID: 22629786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D in liver disease: Current evidence and potential directions.
    Elangovan H; Chahal S; Gunton JE
    Biochim Biophys Acta Mol Basis Dis; 2017 Apr; 1863(4):907-916. PubMed ID: 28064017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Morphological changes of the liver in metabolic disorders].
    Wohlgemuth B
    Dtsch Z Verdau Stoffwechselkr; 1974; 34(1):17-22. PubMed ID: 4442357
    [No Abstract]   [Full Text] [Related]  

  • 20. Liposomes incorporating a Plasmodium amino acid sequence target heparan sulfate binding sites in liver.
    Robertson RT; Baratta JL; Haynes SM; Longmuir KJ
    J Pharm Sci; 2008 Aug; 97(8):3257-73. PubMed ID: 17932963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.